Gofen & Glossberg’s Cavium, Inc. CAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,975
Closed -$262K 497
2017
Q3
$262K Hold
3,975
0.01% 408
2017
Q2
$247K Hold
3,975
0.01% 409
2017
Q1
$285K Hold
3,975
0.01% 377
2016
Q4
$248K Hold
3,975
0.01% 382
2016
Q3
$231K Buy
+3,975
New +$199K 0.01% 397
2016
Q2
Sell
-3,975
Closed -$243K 468
2016
Q1
$243K Hold
3,975
0.01% 390
2015
Q4
$261K Hold
3,975
0.01% 368
2015
Q3
$244K Hold
3,975
0.01% 379
2015
Q2
$274K Sell
3,975
-340
-8% -$23.8K 0.01% 376
2015
Q1
$306K Hold
4,315
0.01% 349
2014
Q4
$267K Hold
4,315
0.01% 379
2014
Q3
$215K Hold
4,315
0.01% 409
2014
Q2
$214K Buy
+4,315
New +$198K 0.01% 410

Other funds holding CAVM

Gofen & Glossberg's CAVM Position: Q4 2017 in Review

Gofen & Glossberg sold out of Cavium, Inc. (CAVM) in Q4 2017, closing a stake of 3,975 shares — an estimated $262K sold.

Gofen & Glossberg first reported a position in CAVM in Q2 2014 and held it in 13 quarters. The position peaked at $306K in Q1 2015. 264 funds tracked by Wall St. Rank hold CAVM as of Q4 2017.

  • Gofen & Glossberg reported no remaining Cavium, Inc. position as of Q4 2017 after selling out during the quarter.
  • Gofen & Glossberg sold 3,975 Cavium, Inc. shares in Q4 2017, an estimated $262K.
  • Gofen & Glossberg first reported a position in Cavium, Inc. in Q2 2014 and held it in 13 quarters.
  • Gofen & Glossberg's Cavium, Inc. position peaked at $306K in Q1 2015.
  • 264 funds tracked by Wall St. Rank held Cavium, Inc. as of Q4 2017.

Based on Gofen & Glossberg's 13F filing for Q4 2017, filed 11 Jan 2018.